Related Experiment Video
Updated: May 9, 2025
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Validity and Reliability of Clinical and Patient-Reported Outcomes in Multisystem Proteinopathy 1
Lindsay N Alfano1,2, Megan A Iammarino1, Natalie F Reash1
1Jerry R. Mendell Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Objective:
Valosin-containing protein (VCP)-associated multisystem proteinopathy 1 (MSP1) is caused by variants in the VCP gene. MSP1 results in various phenotypes including progressive myopathy, Paget's disease of bone, frontotemporal dementia, amyotrophic lateral sclerosis, and parkinsonism, among others. Our study aimed to validate functional clinical outcome assessments (COA) and patient-reported outcomes (PRO) to inform clinical care practices and future clinical trial design. In addition, we evaluated the test-retest reliability of these COAs within clinics and remote environments.
Methods:
Patients completed a battery of COA and PRO across a 2-day traditional onsite visit and a 2-day remote visit within their home environment. All COA and PRO deemed safe and feasible to complete based on participants' level of function and/or home environment were collected at each visit.
Results:
Forty-six total patients enrolled in our study, 34 in our full study and 12 in an expanded remote-only cohort. Functional COA measured decline over reported disease duration in this cross-sectional group and significantly correlated with PRO (rho > 0.5, p < 0.001). Differences in lower and upper extremity involvement were noted across variant groups. Performance of functional COA was reliable and safe within and across onsite and remote testing environments (ICC > 0.7, p < 0.001).
Interpretation:
Functional COA and PRO are valid and reliable to measure abilities in participants with MSP1. Testing can be completed reliably within the home, which could expand equitable access to clinical care and/or future clinical trial participation. Prospective longitudinal data collection is ongoing to understand outcome sensitivity and meaningful change over time.
Insights
Functional clinical outcome assessments and patient-reported outcomes are reliable for measuring abilities in individuals with Valosin-containing protein (VCP)-associated multisystem proteinopathy 1 (MSP1). Home-based testing enhances access to care and clinical trials.
Area of Science:
- Neurology
- Genetics
- Clinical Research
Background:
- Valosin-containing protein (VCP)-associated multisystem proteinopathy 1 (MSP1) is a genetic disorder caused by VCP gene variants.
- MSP1 presents with diverse phenotypes including myopathy, Paget's disease of bone, frontotemporal dementia, ALS, and parkinsonism.
Purpose of the Study:
- To validate functional clinical outcome assessments (COA) and patient-reported outcomes (PRO) for MSP1.
- To assess the test-retest reliability of COAs in both clinical and remote settings.
- To inform clinical care practices and future clinical trial design for MSP1.
Main Methods:
- Patients with MSP1 completed COAs and PROs during a 2-day onsite visit and a 2-day remote visit.
- Assessments were selected based on safety, feasibility, and participant function.
- Data were collected from 46 patients, including a remote-only cohort.
Main Results:
- Functional COAs significantly correlated with PROs (rho > 0.5, p < 0.001), reflecting disease duration.
- COA performance demonstrated high reliability and safety across onsite and remote environments (ICC > 0.7, p < 0.001).
- Variations in limb involvement were observed among different genetic variant groups.
Conclusions:
- Functional COAs and PROs are valid and reliable tools for assessing individuals with MSP1.
- Remote testing facilitates equitable access to clinical care and research participation.
- Ongoing longitudinal data collection will determine outcome sensitivity and meaningful change over time.
Related Concept Videos
01:21Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...